PLASMA FIBROBLAST GROWTH FACTOR-21 (FGF-21) LEVELS IN PATIENTS WITH PERIPHERAL ARTERY DISEASE (PAD)

被引：0
|
作者：
Miyazaki, Yoshichika [1 ]
Saita, Emi [2 ]
Miura, Kotaro [1 ]
Seki, Toshiki [1 ]
Suzuki-Sugihara, Norie [2 ]
Ikegami, Yukinori [1 ]
Ohmori, Reiko [3 ]
Kishimoto, Yoshimi [2 ]
Kondo, Kazuo [2 ]
Momiyama, Yukihiko [1 ]
机构：
[1] Natl Hosp Org Tokyo Med Ctr, Tokyo, Japan
[2] Ochanomizu Univ, Tokyo, Japan
[3] Utsunomiya Univ, Utsunomiya, Tochigi, Japan
来源：
ATHEROSCLEROSIS | 2017年 / 263卷
关键词：
D O I：
10.1016/j.atherosclerosis.2017.06.628
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PO275
引用
收藏
页码：E195 / E196
页数：2
相关论文
共 50 条
  • [1] Low Plasma Levels of Fibroblast Growth Factor-21 in Patients With Peripheral Artery Disease
    Miyazaki, Yoshichika
    Saita, Emi
    Seki, Toshiki
    Miura, Kotaro
    Ikegami, Yukinori
    Kishimoto, Yoshimi
    Kondo, Kazuo
    Momiyama, Yukihiko
    CIRCULATION, 2017, 136
  • [2] Low Plasma Levels of Fibroblast Growth Factor-21 in Patients with Peripheral Artery Disease
    Miyazaki, Yoshichika
    Saita, Emi
    Kishimoto, Yoshimi
    Ibe, Susumu
    Seki, Toshiki
    Miura, Kotaro
    Suzuki-Sugihara, Norie
    Ikegami, Yukinori
    Ohmori, Reiko
    Kondo, Kazuo
    Momiyama, Yukihiko
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2018, 25 (09) : 821 - 828
  • [3] Fibroblast Growth Factor-21 (FGF-21): A Mediator of Inflammatory Responses to Diets?
    Dixon, Taylor M.
    Sharma, Shaligram
    Forney, Laura A.
    Gettys, Thomas W.
    Wanders, Desiree
    DIABETES, 2017, 66 : A679 - A679
  • [4] Changes of plasma fibroblast growth factor-21 (FGF-21) in oral glucose tolerance test and effects of metformin on FGF-21 levels in type 2 diabetes mellitus
    Zhang, Mei
    Liu, Ying
    Xiong, Zhong-yun
    Deng, Zhi-yong
    Song, Hao-lan
    An, Zhen-Mei
    ENDOKRYNOLOGIA POLSKA, 2013, 64 (03) : 220 - 224
  • [5] The Association of Impaired Fasting Glucose and Serum Fibroblast Growth Factor-21 (FGF-21)
    Kim, Hanbyul
    Cho, Hochan
    DIABETES, 2018, 67
  • [6] Fibroblast Growth Factor-21 (FGF-21) predicts development of diabetes and pioglitazone attenuates the increase in FGF-21 in subjects with IGT: results from the ACTNOW study
    Tripathy, D.
    Alonzo, R. P.
    Chavez-Velazquez, A.
    Martinez, R.
    Musi, N.
    Defronzo, R.
    DIABETOLOGIA, 2016, 59 : S164 - S164
  • [7] Fibroblast Growth Factor-21 (FGF-21) as a Novel Marker of Metabolic Complications in Type 2 Diabetes and Obesity
    Matuszek, Beata
    Lenart-Lipinska, Monika
    Duma, Dariusz
    Solski, Janusz
    Nowakowski, Andrzej
    DIABETES, 2010, 59 : A562 - A562
  • [8] Fibroblast growth factor-21 (FGF-21), a novel peptide, is associated with whole body and hepatic insulin resistance
    Chavez, Alberto O.
    Molina-Carrion, Marjorie
    Abdul-Ghani, Muhammad
    Folli, Franco
    De-Fronzo, Ralph A.
    Tripathy, Devjit
    DIABETES, 2008, 57 : A33 - A34
  • [9] Plasma fibroblast growth factor-21 levels in patients with inborn errors of metabolism
    Kirmse, Brian
    Cabrerra-Luque, Juan
    Ayyub, Omar
    Cusmano, Kristina
    Chapman, Kimberly
    Summar, Marshall
    MOLECULAR GENETICS AND METABOLISM REPORTS, 2017, 13 : 52 - 54
  • [10] Fibroblast growth factor-21 (FGF-21) synergizes with insulin in human adipose stem cell-derived (hASC) adipocytes
    Brenner, M. B.
    Lee, D. V.
    Bernardo, B.
    Talukdar, S.
    DIABETOLOGIA, 2012, 55 : S226 - S226
12345